McKesson Corporation (M1CK34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 80.88 |
|---|---|
| 52-week range | 55.71 – 86.11 |
| Return, 1 month / 3 months | +15.7% / +17.1% |
| Return, 1 year / 3 years | +19.0% / +135.3% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -31.6% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | 14.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
McKesson Corporation is a healthcare distribution and services company based in the United States. It distributes prescription medicines, medical supplies and related products to pharmacies, hospitals, clinics and other healthcare providers. The company also offers pharmacy management services and healthcare information technology that help providers manage medicines and clinical operations. Its customers include retail pharmacies, health systems and manufacturers that rely on it to move products through the supply chain.
McKesson Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code M1CK34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
McKesson Corporation (M1CK34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 80.88 on 27 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 288 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.0% and over the last three months it rose 17.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.1% | ||
| From 52-week high | -3.2% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.1% | ||
| 6-month return | 26.2% | ||
| 12-month return, skipping the last month | 2.9% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.6% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 10.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 14.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +15.7% |
| 3 months | +17.1% |
| 6 months | +26.2% |
| 1 year | +19.0% |
| 3 years | +135.3% |
| 5 years | +368.5% |
Signals
| 50-day / 200-day average | 72.85 / 69.06 |
|---|---|
| Golden / death cross (60 days) | Golden, 30 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Aug 2026 | USD 0.0537 |
| 29 May 2026 | USD 0.7453 |
| 27 Feb 2026 | USD 0.7411 |
| 28 Nov 2025 | USD 0.7798 |
| 1 Sep 2025 | USD 0.7669 |
| 30 May 2025 | USD 0.6773 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.